Table 4.
Results of univariate analysis of MACE at mid-term follow-up in DES-ISR patients.
| Variables | OR | 95% CI | P value |
| Age | 0.982 | 0.942–1.023 | 0.382 |
| Male | 0.998 | 0.354–2.812 | 0.997 |
| BMI | 1.000 | 0.878–1.140 | 0.996 |
| Early ISR | 10.300 | 4.095–25.910 | <0.001 |
| Hypertension | 0.916 | 0.375–2.240 | 0.848 |
| Hyperlipidemia | 0.871 | 0.242–3.129 | 0.832 |
| Diabetes mellitus | 0.646 | 0.257–1.620 | 0.351 |
| CKD | – | – | 0.999 |
| History of smoking | 0.754 | 0.323–1.757 | 0.512 |
| Presentation with MI | 0.658 | 0.083–5.238 | 0.693 |
| Left ventricular diastolic dysfunction | – | – | 0.999 |
| Left ventricular systolic dysfunction | 2.980 | 0.581–15.269 | 0.190 |
| NLR | 0.795 | 0.503–1.257 | 0.327 |
| ESR | 0.992 | 0.948–1.038 | 0.720 |
| Implanting stent | 0.723 | 0.307–1.704 | 0.459 |
| Success of index PCI | 0.324 | 0.083–1.270 | 0.106 |
95% CI: 95% confidence interval; BMI: Body mass index; CKD: Chronic kidney disease; DES: Drug-eluting stent; ESR: Erythrocyte sedimentation rate; ISR: In-stent restenosis; MACE: Major adverse cardiac events; MI: Myocardial infarction; NLR: Ratio of neutrophil to lymphocyte; OR: Odds ratio; PCI: Percutaneous coronary intervention.